Paper19155308
A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis.
Hu MG and 12 others. Cancer Res, 2009. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. Papers, record 19155308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19155308
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Cyclin-Dependent Kinase 6 | Major topic |
| T-Lymphocytes | Major topic |
| Thymus Gland | Major topic |
| Thymus Neoplasms | Major topic |
| Animals | |
| Apoptosis | |
| Cell Differentiation | |
| Cell Growth Processes | |
| Female | |
| Lymphoma | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Mice, Transgenic | |
| Oncogene Protein v-akt | |
| Receptors, Notch |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DE015302 | NIDCR NIH HHS | United States | R01DE015302 | PubMed and NIH | NIH RePORTER |
| R01 CA127392 | NCI NIH HHS | United States | R01CA127392 | PubMed and NIH | NIH RePORTER |
| R01 DE015302 | NIDCR NIH HHS | United States | R01DE015302 | PubMed and NIH | NIH RePORTER |
| CA096527 | NCI NIH HHS | United States | R01CA096527 | PubMed and NIH | NIH RePORTER |
| R01 CA096527 | NCI NIH HHS | United States | R01CA096527 | PubMed and NIH | NIH RePORTER |
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11752445 | Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11752445 | PubMed |
| 2 | 10879740 | Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas. | Lab Invest | 2000 | https://conductscience.org/library/papers/10879740 | PubMed |
| 3 | 11927910 | Tracing lymphopoiesis with the aid of a pTalpha-controlled reporter gene. | Nat Immunol | 2002 | https://conductscience.org/library/papers/11927910 | PubMed |
| 4 | 14592976 | Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. | EMBO J | 2003 | https://conductscience.org/library/papers/14592976 | PubMed |
| 5 | 16153702 | Core transcriptional regulatory circuitry in human embryonic stem cells. | Cell | 2005 | https://conductscience.org/library/papers/16153702 | PubMed |
| 6 | 9792703 | Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9792703 | PubMed |
| 7 | 16056227 | Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. | Nat Immunol | 2005 | https://conductscience.org/library/papers/16056227 | PubMed |
| 8 | 10367900 | Deficient T cell fate specification in mice with an induced inactivation of Notch1. | Immunity | 1999 | https://conductscience.org/library/papers/10367900 | PubMed |
| 9 | 15288258 | Notch and T cell malignancy. | Semin Cancer Biol | 2004 | https://conductscience.org/library/papers/15288258 | PubMed |
| 10 | 9422538 | Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. | Am J Pathol | 1998 | https://conductscience.org/library/papers/9422538 | PubMed |
| 11 | 14647273 | High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division. | Nat Immunol | 2004 | https://conductscience.org/library/papers/14647273 | PubMed |
| 12 | 12172006 | Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12172006 | PubMed |
| 13 | 17989712 | Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma. | Leukemia | 2008 | https://conductscience.org/library/papers/17989712 | PubMed |
| 14 | 9832503 | Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. | Genes Dev | 1998 | https://conductscience.org/library/papers/9832503 | PubMed |
| 15 | 18039126 | Notch signaling in leukemia. | Annu Rev Pathol | 2008 | https://conductscience.org/library/papers/18039126 | PubMed |
| 16 | 14566327 | Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. | EMBO Rep | 2003 | https://conductscience.org/library/papers/14566327 | PubMed |
| 17 | 11686294 | PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? | J Cell Sci | 2001 | https://conductscience.org/library/papers/11686294 | PubMed |
| 18 | 14744761 | Role of p12(CDK2-AP1) in transforming growth factor-beta1-mediated growth suppression. | Cancer Res | 2004 | https://conductscience.org/library/papers/14744761 | PubMed |
| 19 | 15950907 | Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). | Cancer Cell | 2005 | https://conductscience.org/library/papers/15950907 | PubMed |
| 20 | 16782810 | Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16782810 | PubMed |
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42881166 | Ablation of CDK6 and STAT5B rewires T cell developmental dynamics and prevents ALK+ lymphoma formation. | Nat Commun | 2026 | https://conductscience.org/library/papers/42881166 | PubMed |
| 41943159 | Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/41943159 | PubMed |
| 41880186 | Leiomodin 1 haploinsufficiency promotes smooth muscle cell proliferation and increases neointimal lesion size. | Vascul Pharmacol | 2025 | https://conductscience.org/library/papers/41880186 | PubMed |
| 41463246 | The Dual Effects of CDK4/6 Inhibitors on Tumor Immunity. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41463246 | PubMed |
| 41102383 | LILRB4 regulates circadian disruption-induced mammary tumorigenesis via non-canonical WNT signaling pathway. | Oncogene | 2025 | https://conductscience.org/library/papers/41102383 | PubMed |
| 40948552 | Genome-wide association analysis of neutrophil granularity identifies CDK6 as a regulator of primary granules. | iScience | 2025 | https://conductscience.org/library/papers/40948552 | PubMed |
| 40692275 | Targeting CDK2 and other novel cell cycle targets for breast cancer therapy. | Expert Opin Ther Targets | 2025 | https://conductscience.org/library/papers/40692275 | PubMed |
| 40486867 | Cell cycle proteins: Linking the cell cycle to tumors. | Oncol Res | 2025 | https://conductscience.org/library/papers/40486867 | PubMed |
| 39966356 | CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/39966356 | PubMed |
| 39940918 | CDK6-Dependent, CDK4-Independent Synovial Hyperplasia in Arthritic Mice and Tumor Necrosis Factor-α-Induced Proliferation of Synovial Fibroblasts. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39940918 | PubMed |
| 39800748 | Cyclin-dependent protein kinases and cell cycle regulation in biology and disease. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/39800748 | PubMed |
| 39781622 | Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma. | Haematologica | 2025 | https://conductscience.org/library/papers/39781622 | PubMed |
| 39593745 | Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer Treatment: Challenges and Perspectives. | Bioengineering (Basel) | 2024 | https://conductscience.org/library/papers/39593745 | PubMed |
| 38316780 | CDK6 inhibits de novo lipogenesis in white adipose tissues but not in the liver. | Nat Commun | 2024 | https://conductscience.org/library/papers/38316780 | PubMed |
| 38212482 | Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. | Br J Cancer | 2024 | https://conductscience.org/library/papers/38212482 | PubMed |
| 37958642 | Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958642 | PubMed |
| 37893220 | Immunological Phenotyping of Mice with a Point Mutation in Cdk4. | Biomedicines | 2023 | https://conductscience.org/library/papers/37893220 | PubMed |
| 37664186 | CDK6 is essential for mesenchymal stem cell proliferation and adipocyte differentiation. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/37664186 | PubMed |
| 36819538 | XTP1 facilitates the growth and development of gastric cancer by activating CDK6. | Ann Transl Med | 2023 | https://conductscience.org/library/papers/36819538 | PubMed |
| 36768557 | Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 Inhibitors in the Tumor Microenvironment. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768557 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CCND2 | 894 | PubTator's text mining | https://conductscience.org/library/genes/894 | NCBI Gene |
| CCND3 | 896 | PubTator's text mining | https://conductscience.org/library/genes/896 | NCBI Gene |
| CDK2 | 1017 | PubTator's text mining | https://conductscience.org/library/genes/1017 | NCBI Gene |
| CDK4 | 1019 | PubTator's text mining | https://conductscience.org/library/genes/1019 | NCBI Gene |
| CDK6 | 1021 | PubTator's text mining | https://conductscience.org/library/genes/1021 | NCBI Gene |
| PCNA | 5111 | PubTator's text mining | https://conductscience.org/library/genes/5111 | NCBI Gene |
| TCF3 | 6929 | PubTator's text mining | https://conductscience.org/library/genes/6929 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19155308
GET https://conductscience.org/api/papers/v1/19155308/references?page=2